Der blev indberettet om fald til under 0, 5 x 109/ l hos 0, 3% af de patienter, som fik tocilizumab 8 mg/ kg plus DMARDs.
Decreases below 0.5 x 109/ l were reported in 0.3% patients receiving tocilizumab 8 mg/ kg plus DMARDs.